ClearPoint Neuro Inc. (CLPT)
NASDAQ
9.14
-0.11 (-1.19%)
Delayed Data
Oct 23, 2026, 01:30 PM
Day's Range
8.959.22
52 wk Range
8.2727.27
Financial Statements - CLPT - ClearPoint Neuro Inc.
Revenue
36.97M▲ 17.8%
Net Income
-25.54M▼ 35.0%Net Margin -69.1%
EBITDA
-20.86M▼ 16.9%
Free Cash Flow
-24.44M▼ 165.0%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 36.97M | 31.39M | 23.95M | 20.55M | 16.29M | 12.82M |
| Cost of Goods | 14.27M | 12.26M | 10.34M | 7.02M | 5.17M | 3.70M |
| Gross Profit | 22.69M | 19.12M | 13.61M | 13.53M | 11.12M | 9.12M |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -24.16M | -19.74M | -22.44M | -16.33M | -13.37M | -6.22M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | -146K | -40K | -29K | -22K | -63K | 882K |
| Pre Tax Income | -25.48M | -18.91M | -22.08M | -16.43M | -14.41M | -6.78M |
| Income Tax | 55K | - | - | - | - | - |
| Net Income | -25.54M | -18.91M | -22.08M | -16.43M | -14.41M | -6.78M |
| EPS Basic | -0.9 | -0.7 | -0.9 | -0.68 | -0.69 | -0.43 |
| EPS Diluted | -0.9 | -0.7 | -0.9 | -0.68 | -0.69 | -0.43 |
| Basic Shares Outstanding | 28.31M | 27.02M | 24.60M | 24.18M | 20.73M | 15.84M |
| Diluted Shares Outstanding | 28.31M | 27.02M | 24.60M | 24.18M | 20.73M | 15.84M |
| Ebit | -23.09M | -19.74M | -22.44M | -16.35M | -13.43M | -5.33M |
| Ebitda | -20.86M | -17.84M | -20.98M | -15.57M | -12.74M | -4.78M |
| Net Income Continuous Operations | -25.54M | -18.91M | -22.08M | -16.43M | -14.41M | -6.78M |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
